Mimi K.
- Country
- Denmark
- Department
- Department of Paediatrics and Adolescent Medicine
Research Overview
- Phase I/II Umbrella Trial of Ulixertinib, Tovorafenib, and Vinblastine Sulfate in Pediatric Patients with Progressive, Relapsed, or Refractory Low-Grade Glioma
- Phase 1b/2 Study of Ifinatamab Deruxtecan in Pediatric Patients with Relapsed or Refractory Solid Tumors (Neuroblastoma, Rhabdomyosarcoma, Wilms Tumor, Osteosarcoma)
- Phase 1/2 Evaluation of Cobolimab and Dostarlimab in Pediatric and Young Adult Patients with Newly Diagnosed and Relapsed/Refractory Solid Tumors
Data & Insights
Has run more than one trial at 19 of 49 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating advanced solid tumors in pediatric and young adult patients, with particular emphasis on developing innovative combination therapy approaches.
- High-grade glioma management
- Relapsed and refractory tumor treatments
- Post-radiotherapy interventions
The research focus includes evaluating novel therapeutic combinations for young patients with challenging oncological conditions.
Specialized Cancer Treatments
The investigator focuses on treating specific cancer types including melanoma and Hodgkin lymphoma, exploring targeted therapeutic approaches for these conditions.
- Combination immunotherapy protocols
- Advanced solid tumor therapeutics
- Chemotherapy optimization strategies
Their work encompasses the development of targeted treatments for specific cancer pathologies in younger populations.
Drug Development
The investigator evaluates novel therapeutic agents including abemaciclib, cobolimab, and dostarlimab for pediatric and young adult cancer treatment.
- Safety and tolerability assessments
- Pharmacokinetic profiling
- Therapeutic dose optimization
Their expertise extends to determining optimal dosing and evaluating drug combinations for enhanced therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.